Market Research Logo

T-Cell Immunotherapy Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

T-Cell Immunotherapy Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

The report on global t-cell immunotherapy market provides qualitative and quantitative analysis for the period of 2016 to 2024. The report predicts the global t-cell immunotherapy market to grow with a healthy CAGR over the forecast period of 2018-2024. The study on t-cell immunotherapy market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific and RoW for the period of 2016 to 2024.
The growing occurrence of cancer in the both children as well as in adults creates the huge demand for effective treatments. The rising incidence of cancer across the globe is key factor driving the growth of T cell immunotherapy market. Reliable and effective treatments offered by the T cell with the minimum side effects as compared to the other traditional therapies are contributing in the growth of T cell immunotherapy market. In addition, on-going development to improve the existing therapies and rising innovations to provide more effective therapy options are anticipated to boost the growth of T cell immunotherapy market. However, the neurological problems associated with the T cell immunotherapy is expected to be the restraining factor in the T cell immunotherapy market. Moreover, various health organizations and government agencies are taking initiative to find effective therapy to treat cancer. The rapidly increasing research and development activities and technological advancement in the cancer treatment are projected to create several opportunities for the T cell immunotherapy market in upcoming years.
Furthermore, The Food and Drug Administration (FDA) has approved CAR T-cell therapy, axicabtagene ciloleucel (Yescarta), for the treatment of diffuse large B-cell lymphoma (DLBCL) and CAR T-cell therapy tisagenlecleucel (Kymriah) to treat cancer in the Childers and adults.
The report on t-cell immunotherapy market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global t-cell immunotherapy market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.
Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global t-cell immunotherapy market over the period of 2016 to 2024. Further, IGR- Growth Matrix given in the report brings an insight on the investment areas that existing or new market players can consider.

Research Methodology
A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached through
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from LinkedIn, Hoovers, Factiva and Bloggers
Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.
B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.
The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global t-cell immunotherapy market is segmented on the basis of mechanism of action, type of therapy and product class.

Global T-cell Immunotherapy Market by Mechanism of Action
Active Immunotherapy
Passive Immunotherapy
Global T-cell Immunotherapy Market by Type of Therapy
CAR-T
TCR
TIL
Global T-cell Immunotherapy Market by Product Class
Monoclonal Antibodies
Oncolytic Virus Therapy
Bispecific Antibodies
Cytokines

Company Profiles
Adaptimmune Therapeutics
bluebird bio
bluebird bio
nnovative Cellular Therapeutics
Novartis
Sinobioway Cell Therapy
Cellectis
CARsgen Therapeutics
Autolus
Celgene

How this report delivers?
1. Comprehensive analysis of global as well as regional markets of t-cell immunotherapy market.
2. Complete coverage of all the segments in t-cell immunotherapy market to analyze the trends, developments in the global market and forecast of market size up to 2024.
3. Comprehensive analysis of the companies operating in global t-cell immunotherapy market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.


The report on t-cell immunotherapy market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global t-cell immunotherapy market over the period of 2016 to 2024. Moreover, the report is collective presentation of primary and secondary research findings.

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. T-Cell Immunotherapy Market Highlights
2.2. T-Cell Immunotherapy Market Projection
2.3. T-Cell Immunotherapy Market Regional Highlights
3. Global T-Cell Immunotherapy Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Mechanism Of Action
3.4.2. IGR-Growth Matrix Analysis by Type Of Therapy
3.4.3. IGR-Growth Matrix Analysis by Product Class
3.4.4. IGR-Growth Matrix Analysis by Region
3.5. Value chain t-cell immunotherapy market
3.6. Import-Export data matrix
4. T-Cell Immunotherapy Market Macro Indicator Analysis
5. Global T-Cell Immunotherapy Market by Mechanism Of Action
5.1. Active Immunotherapy
5.2. Passive Immunotherapy
6. Global T-Cell Immunotherapy Market by Type of Therapy
6.1. CAR-T
6.2. TCR
6.3. TIL
7. Global T-Cell Immunotherapy Market by Product Class
7.1. Monoclonal Antibodies
7.2. Oncolytic Virus Therapy
7.3. Bispecific Antibodies
7.4. Cytokines
8. Global T-Cell Immunotherapy Market by Region 2018-2024
8.1. North America
8.1.1. North America T-Cell Immunotherapy Market by Mechanism Of Action
8.1.2. North America T-Cell Immunotherapy Market by Type Of Therapy
8.1.3. North America T-Cell Immunotherapy Market by Product Class
8.1.4. North America T-Cell Immunotherapy Market by Country
8.2. Europe
8.2.1. Europe T-Cell Immunotherapy Market by Mechanism Of Action
8.2.2. Europe T-Cell Immunotherapy Market by Type Of Therapy
8.2.3. Europe T-Cell Immunotherapy Market by Product Class
8.2.4. Europe T-Cell Immunotherapy Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific T-Cell Immunotherapy Market by Mechanism Of Action
8.3.2. Asia-Pacific T-Cell Immunotherapy Market by Type Of Therapy
8.3.3. Asia-Pacific T-Cell Immunotherapy Market by Product Class
8.3.4. Asia-Pacific T-Cell Immunotherapy Market by Country
8.4. RoW
8.4.1. RoW T-Cell Immunotherapy Market by Mechanism Of Action
8.4.2. RoW T-Cell Immunotherapy Market by Type Of Therapy
8.4.3. RoW T-Cell Immunotherapy Market by Product Class
8.4.4. RoW T-Cell Immunotherapy Market by Sub-region
9. Company Profiles and competitive Landscape
9.1. Competitive Landscape in the Global T-cell Immunotherapy Market
9.2. Companies Profiles
9.2.1. Adaptimmune Therapeutics
9.2.1.1. Overview
9.2.1.2. Company Snapshot
9.2.1.3. Financial Snapshot
9.2.1.4. Product portfolio
9.2.1.5. Recent developments
9.2.2. Bluebird Bio
9.2.2.1. Overview
9.2.2.2. Company Snapshot
9.2.2.3. Financial Snapshot
9.2.2.4. Product portfolio
9.2.2.5. Recent developments
9.2.3. Bluebird Bio
9.2.3.1. Overview
9.2.3.2. Company Snapshot
9.2.3.3. Financial Snapshot
9.2.3.4. Product portfolio
9.2.3.5. Recent developments
9.2.4. Nnovative Cellular Therapeutics
9.2.4.1. Overview
9.2.4.2. Company Snapshot
9.2.4.3. Financial Snapshot
9.2.4.4. Product portfolio
9.2.4.5. Recent developments
9.2.5. Novartis
9.2.5.1. Overview
9.2.5.2. Company Snapshot
9.2.5.3. Financial Snapshot
9.2.5.4. Product portfolio
9.2.5.5. Recent developments
9.2.6. Sinobioway Cell Therapy
9.2.6.1. Overview
9.2.6.2. Company Snapshot
9.2.6.3. Financial Snapshot
9.2.6.4. Product portfolio
9.2.6.5. Recent developments
9.2.7. Cellectis
9.2.7.1. Overview
9.2.7.2. Company Snapshot
9.2.7.3. Financial Snapshot
9.2.7.4. Product portfolio
9.2.7.5. Recent developments
9.2.8. Carsgen Therapeutics
9.2.8.1. Overview
9.2.8.2. Company Snapshot
9.2.8.3. Financial Snapshot
9.2.8.4. Product portfolio
9.2.8.5. Recent developments
9.2.9. Autolus
9.2.9.1. Overview
9.2.9.2. Company Snapshot
9.2.9.3. Financial Snapshot
9.2.9.4. Product portfolio
9.2.9.5. Recent developments
9.2.10. Celgene
9.2.10.1. Overview
9.2.10.2. Company Snapshot
9.2.10.3. Financial Snapshot
9.2.10.4. Product portfolio
9.2.10.5. Recent developments
10. Appendix
10.1. Primary research findings and questionnaire

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report